(Q37607912)

21 August 2017

1 reference

title

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes (English)

1 reference

21 August 2017

0 references

0 references

0 references

7

Carine Van Lint

0 references

Olivier Rohr

8

object named as

Olivier Rohr

1 reference

21 August 2017

Laetitia Redel

1

1 reference

21 August 2017

Valentin Le Douce

2

1 reference

21 August 2017

Thomas Cherrier

3

1 reference

21 August 2017

Céline Marban

4

1 reference

21 August 2017

Andrea Janossy

5

1 reference

21 August 2017

Dominique Aunis

6

1 reference

21 August 2017

Christian Schwartz

9

1 reference

21 August 2017

publication date

2 October 2009

1 reference

Journal of Leukocyte Biology

21 August 2017

published in

1 reference

21 August 2017

volume

87

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

575-588

1 reference

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Hide-and-seek: the challenge of viral persistence in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Latency in human immunodeficiency virus type 1 infection: no easy answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Cellular reservoirs of HIV-1 and their role in viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The role of monocytes and macrophages in the pathogenesis of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Macrophages and HIV-1: dangerous liaisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Infectious HIV-1 assembles in late endosomes in primary macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Human macrophages accumulate HIV-1 particles in MHC II compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Infection of monocyte/macrophages by human T lymphotropic virus type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Experimental approaches to the study of HIV-1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Nuclear organization and the control of HIV-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Generation of HIV latency during thymopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Active nuclear import of human immunodeficiency virus type 1 preintegration complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Retroviral E-DNA: persistence and gene expression in nondividing immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Human macrophages support persistent transcription from unintegrated HIV-1 DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Latency: the hidden HIV-1 challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 integration in the human genome favors active genes and local hotspots

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Transcription start regions in the human genome are favored targets for MLV integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The multifactorial nature of HIV-1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Transcriptional interference antagonizes proviral gene expression to promote HIV latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Determinants of the establishment of human immunodeficiency virus type 1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Oscillations in NF-kappaB signaling control the dynamics of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Transient-mediated fate determination in a transcriptional circuit of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 infection and regulation of Tat function in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Receptor tyrosine kinases and the regulation of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

RON receptor tyrosine kinase, a negative regulator of inflammation, inhibits HIV-1 transcription in monocytes/macrophages and is decreased in brain tissue from patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Signal transduction induced by apoptotic cells inhibits HIV transcription in monocytes/macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Is HIV infection a TNF receptor signalling-driven disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Histone and chromatin cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Role of chromatin in HIV-1 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Regulation of HIV-1 latency by T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Tat gets the "green" light on transcription initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The regulation of human immunodeficiency virus type-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Methylation-induced repression--belts, braces, and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 expression induced by anti-cancer agents in latently HIV-1-infected ACH2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Epigenetic regulation of HIV-1 latency by cytosine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The regulation of genes and genomes by small RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Suppression of microRNA-silencing pathway by HIV-1 during virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

An HIV vaccine--evolving concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV pharmacology: barriers to the eradication of HIV from the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Recent status of HIV-1 gene expression inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Tat as a transcriptional activator and a potential therapeutic target for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Cellular factors as alternative targets for inhibition of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

New anti-HIV agents and targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

DING proteins; novel members of a prokaryotic phosphate-binding protein superfamily which extends into the eukaryotic kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

St. John's Wort protein, p27SJ, regulates the MCP-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

CD154-CD40-induced reactivation of latent HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Effects of prostratin on T-cell activation and human immunodeficiency virus latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Histone acetyltransferases regulate HIV-1 enhancer activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Caspase inhibitors as a supplement in immune activation therapies to achieve eradication of HIV in its latent reservoirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Amphotericin-B-mediated reactivation of latent HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The therapeutic uses of chromatin-modifying agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Stability of the latent reservoir for HIV-1 in patients receiving valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0409264

21 January 2018

Identifiers

DOI

10.1189/JLB.0409264

1 reference

release_x2p23xnyczbe7prz7omoceufsu

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x2p23xnyczbe7prz7omoceufsu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference